The Honourable Greg Hunt served in the Australian Government as Minster for Health and Aged Care from 2017, previously as Industry, Innovation and Science Minister and before that the Environment Minister.
Elected as the Member for Flinders in 2001, Greg announced his retirement from politics late 2021 and in 2022, ahead of the Federal Election, having completed 20 years as a public servant.
Australian Health Journal recently caught up with Greg in a relaxed interview at his home in the Mornington Peninsula, Victoria to hear how a 9 month sabbatical has allowed him to focus on family, fitness and future. This has even included some “brutal spin cycle classes!”.
In his Ministerial role, Greg reflects on the critical supply of masks, gloves, gowns, tests, vaccines and ventilators during the initial years of the COVID-19 pandemic.
Greg talks about Australia’s sovereign capability in a post-COVID-19 world which has played a part on delivering 98% vaccine uptake across Australians, and with some of the lowest rates of death from COVID. He references the structural platform in place with the Medical Research Future Fund, R&D Tax Concession and the Patent Box.
Looking ahead, precision health as a service, stem cells and genomics are key trends that will define the future workforce through targeted treatments, according to Greg. He states with optimism that innovation, research and investment, can make the country a global leader.
He’s also is optimistic the country is well placed with the quality of the workforce, the training in place and the balance between public and private health.
In conclusion Greg, talks to you, the health industry on the support he received both in office and after, and thanks the industry for the treatment delivered to every Australian patient.
Now Greg is moving his attention to 3 pillars – Academic, Philanthropic and Commercial.
Today Greg is the foundation Chair of the Turner Institute for Brain and Mental Health’s Advisory Council, at Monash University in Melbourne. The Turner Institute is a world leader in research dedicated to preventative brain and mental health research, treatment and education, a focus for Greg.
Australian Health Journal wishes Greg the best in his future endeavours.
-
Making clinical trials participant friendly
Clinical trials are essential in developing new, improved, and more effective treatments and interventions. Without trials, researchers and professionals in the field cannot properly determine whether these new treatments and interventions are safe and effective.
The Clinials platform is geared towards patient centric trials and reducing site burden. The aim is to accelerate lifesaving medicines coming to market by connecting participants and researchers. The platform allows participants to come to researchers with their eligibility in hand among other capabilities.
-
Priming Australia for social prescribing
Social prescribing provides support in various areas of people’s lives, leading to increased confidence, improved navigation of systems, and enhanced friendships and trust in healthcare, while communities should be designed in an age-friendly way to prevent isolation.
In Part 1 of the Models of Care on Social Prescribing, Australian Health Journal spoke to 4 people advocating for social prescribing in Australia
-
Strategic research investments for health and prosperity
The CEO of Research Australia, Nadia Levin spoke with Australian Health Journal about the following:
– Current medical research and development landscape in Australia
– Investment required to support the Health and Medical Research and Innovation pipeline
– The National Medical Products Industry Plan and its impact on the Australian economy
– The Health and Medical Research WorkforceIn the lead up to the Australian Federal Budget in May 2023, Australian Health Journal reached out to peak health industry bodies to hear about their priorities, either noted in pre-budget submissions lodged with Federal Government in January 2023 or in recent forums such as the Strengthening Medicare Taskforce.
